SC For Govt Reply On RTI Voluntary Disclosure

NEW DELHI : More than 16 years after the RTI Act was enacted to usher in transparency in the functioning of governments, writ petitions continue to flood the Supreme Court, which on Friday sought the Centre’s response, albeit reluctantly, on another PIL complaining that public authorities are not complying with the RTI mandate to make voluntary disclosures about their activities.

A bench of Justices Sanjay Kishan Kaul and M M Sundresh issued notice on the PIL filed by advocate K C Jain, who said that Section 4 of the Act is the soul and spirit of the transparency law and without a direction from the apex court to the governments and authorities for its compliance in letter and spirit, the RTI Act would remain an ornamental legislation.

Jain said, “This writ petition seeks implementation of Section 4 of the RTI Act, which is the soul and spirit of the RTI Act. This provision requires proactive and voluntary disclosure of all vital informations relating to functioning of public authorities as has been specified in Section 4. Reports from the Central Information Commission and other organisations indicate that there is very poor compliance of Section 4 mandate. We pray that the mandate of Section 4 be given effect to through SC orders otherwise it would remain an ornamental law.”

He also said the department of personnel and training had issued a office memorandum requiring public authorities to commission third-party audits to scrutinise Section 4 mandated disclosure levels.

But, the Central Information Commission reports of 2018-19 and 2019-20 show that only one-third of the public authorities carried out such public audit and it was found that their performance was very poor, Jain said, adding once the disclosures are as per the mandate of the RTI Act, there would be greater transparency and people would not be required to resort to RTI so often as they do now.

Justice Kaul remained unconvinced. “This is a legislation and there is a mechanism to implement the legislation. I don’t believe in issuing meaningless directions. What is the point of issuing a direction when there is a mandate of the legislation for mode and manner of its implementation. Of course the law and its provisions have to be implemented. What mandamus can be issued by the court? How will we monitor whether such a direction, even if issued, is implemented? It would rather be a meaningless direction.”

The lead judge of the bench asked – “Can the SC say there is a section of RTI Act and there is a OM and hence, all public authorities should follow it? What is the meaning of such a direction? How would we monitor its implementation?

  • Related Posts

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre